Advent Life Sciences
QuietLondon, X0Biotechnology, Healthcare, PharmaceuticalsLast fund filed October 2024
5 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Advent Life Sciences Growth Fund | October 2024 | Indefinite | $9.8M | 1 |
| Advent Life Sciences Fund III | December 2018 | Indefinite | $25M | 3 |
| Advent Life Sciences Fund II | September 2014 | $226M | $226M | 15 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
7 partners are named across this firm’s filings, 5 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| - Advent Life Sciences LLP | Quiet | None listed | 0 | 0 |
Classified sectors of Advent Life Sciences’s own portfolio companies, based on 5 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Advent Life Sciences’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| New Leaf | 2 | Iterum Therapeutics Bermuda, Iterum Therapeutics plc |
| Capra CLO Founders | 1 | Iterum Therapeutics Bermuda |
| Lightstone Singapore | 1 | Moximed |
| Lightstone Ventures |
| Dale PfostNot on the current fund | Quiet | None listed | 5 | 0 |
| Dominic Schmidt | Quiet | None listed | 0 | 0 |
| Kaaism MahmoodNot on the current fund | Quiet | None listed | 0 | 0 |
| Kaasim Mahmood | Quiet | None listed | 0 | 0 |
| Rajesh Parekh | Quiet | None listed | 1 | 0 |
| Shahzad Malik | Quiet | Biotech & pharma, Medical devices | 9 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| 1 |
| Moximed |
| MPM BioVentures | 1 | IDUN PHARMACEUTICALS |
| NEA | 1 | Moximed |
| Orbimed Asia Partners | 1 | Acutus Medical |
| Orbimed Genesis | 1 | Acutus Medical |
| Samsara Biocapital | 1 | Versartis |
| Sofinnova Venture Partners | 1 | Iterum Therapeutics Bermuda |
A shared board seat: a company where filings name a Advent Life Sciences partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.